Literature DB >> 20185015

Effect of motorized scooters on quality of life and cardiovascular risk.

Brian W Zagol1, Richard A Krasuski.   

Abstract

Physical inactivity increases cardiovascular risk. The possible adverse effects of regular motorized scooter use, recently popularized for patients with physical limitations, has not been previously examined. We performed a single-center, retrospective cohort study of 102 consecutive patients who had obtained medical approval for, and subsequently received, a motorized scooter during a 6-year period. The clinical data were collected for the 12 months before and after the intervention. Surveys assessing 11 different facets of health-related quality of life were returned by 28% of patients. The patients receiving a scooter were 68 +/- 19 years old, and 55% were women. The medical indications for scooter use, by decreasing frequency, were disabling arthritis, chronic lung disease, neurologic disorders, and heart failure. Patients returning the surveys estimated scooter use at a median of 4 hours/day, with walking confined to 30 min/day. Despite significant physical and psychological improvements in all quality-of-life categories (p <0.001), the fasting blood glucose increased from 119 +/- 39 to 133 +/- 49 mg/dl (p = 0.009), hemoglobin A1c increased from 6.3 +/- 0.8 to 6.8 +/- 1.2 (p = 0.019), and 18.7% of patients developed diabetes during the follow-up period. No significant changes in blood pressure were noted, although 20% of patients required additional antihypertensive medication. Despite improvements in total and low-density lipoprotein cholesterol over time, 50% of dyslipidemic patients required either an increase medication dose or additional medications during follow-up. In conclusion, interventions, such as scooters, that improve self-perceived quality of life, can have detrimental long-term effects by increasing cardiovascular risk, particularly insulin resistance. Physicians should carefully weigh such risks before approving their use, as well as ensure healthy levels of activity afterward. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20185015     DOI: 10.1016/j.amjcard.2009.10.049

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

1.  Comparison of metabolic cost, performance, and efficiency of propulsion using an ergonomic hand drive mechanism and a conventional manual wheelchair.

Authors:  Lisa A Zukowski; Jaimie A Roper; Orit Shechtman; Dana M Otzel; Jason Bouwkamp; Mark D Tillman
Journal:  Arch Phys Med Rehabil       Date:  2013-09-06       Impact factor: 3.966

2.  Motorised mobility scooters; upper limb fractures in elderly novice users.

Authors:  Colin G Murphy; Ian G Murphy; Kieran S O'Rourke; Kieran O'Shea
Journal:  Clin Cases Miner Bone Metab       Date:  2014-05

Review 3.  Motorized mobility scooters: the use of training/intervention and technology for improving driving skills in aging adults - a mini-review.

Authors:  Nima Toosizadeh; Matthew Bunting; Carol Howe; Jane Mohler; Jonathan Sprinkle; Bijan Najafi
Journal:  Gerontology       Date:  2014-01-24       Impact factor: 5.140

4.  The Implications of Power Mobility on Body Weight in a Veteran Population.

Authors:  Deborah Caruso; Rajbir S Chaggar; Scott D McDonald; Christo X Arbonies; David X Cifu
Journal:  Fed Pract       Date:  2021-09-12

5.  A dietary mixture containing fish oil, resveratrol, lycopene, catechins, and vitamins E and C reduces atherosclerosis in transgenic mice.

Authors:  Lars Verschuren; Peter Y Wielinga; Wim van Duyvenvoorde; Samira Tijani; Karin Toet; Ben van Ommen; Teake Kooistra; Robert Kleemann
Journal:  J Nutr       Date:  2011-03-16       Impact factor: 4.798

6.  The impact of mobility scooters on their users. Does their usage help or hinder?: A state of the art review.

Authors:  Roselle Thoreau
Journal:  J Transp Health       Date:  2015-06

Review 7.  Periodontal pathogens and atherosclerosis: implications of inflammation and oxidative modification of LDL.

Authors:  Tomoko Kurita-Ochiai; Masafumi Yamamoto
Journal:  Biomed Res Int       Date:  2014-05-18       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.